abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Gross Profit Growth
53.84%
TTM · Period ending:
HQL Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported53.84%period ending
Latest reported53.84%period ending
HQL TTM Gross Profit YoY % (-12.85% → 53.84%)
Year-over-year change
High-resolution chart · PNG
HQL gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 53.8421% | |
| -12.2902% | |
| -6.7787% | |
| -40.4471% | |
| 21.6425% | |
| -15.3764% | |
| -31.4477% | |
| -10.3736% | |
| -2.0602% | |
| 100.5213% | |
| 160.4092% | |
| 720.2183% | |
| 1,477.6954% | |
| 256.257% | |
| 55.3237% | |
| 41.1941% | |
| -124,853.491% | |
| -174,646.4416% | |
| 25.016% | |
| 25.4809% | |
| 49.1795% | |
| 72.6397% | |
| -99.8874% | |
| 100.3802% | |
| 193.4914% | |
| 87.9699% | |
| 67.6837% | |
| 23.0526% | |
| -34.4972% | |
| -1.6854% | |
| 10.6965% | |
| 20.5357% | |
| -9.9863% | |
| -58.3039% | |
| -74.0476% | |
| -106.5693% | |
| -7.1429% | |
| 46.2745% | |
| 43.4343% | |
| 41.7808% | |
| 20.0692% | |
| -2.0979% | |
| -7.8358% | |
| -14.4% | |
| -12.2905% | |
| -9.9707% | |
| -11.875% | |
| -14.0468% | |
| -10.3448% | |
| -12.8514% |